Literature DB >> 21618694

Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay.

Omar Massoud1, Julie Heimbach, Kimberly Viker, Anuradha Krishnan, John Poterucha, William Sanchez, Kymberly Watt, Russell Wiesner, Michael Charlton.   

Abstract

The diagnosis of acute cellular rejection (ACR) requires liver biopsy with its attendant expense and risk. Our first aim was to prospectively determine in an exploratory analysis whether there is a serum proteome signature associated with histologically confirmed ACR. Our second aim was to use simpler and faster enzyme-linked immunosorbent assay (ELISA)-based assays for proteins identified as differentially abundant in the proteomic analysis to identify patients with ACR in a separate validation cohort. We used sequential high-abundance protein depletion and isobaric tag for relative and absolute quantitation liquid chromatography-tandem mass spectrometry to characterize the serum proteome in serum samples of patients with or without ACR. Seven of the 41 proteins identified as differentially abundant [serum amyloid A, complement component 4 (C4), fibrinogen, complement component 1q (C1q), complement component 3, heat shock protein 60 (HSP60), and HSP70] could be measured with ELISA-based assays in a validation cohort consisting of patients with ACR (n = 25) and patients without ACR (n = 21). The mean alanine aminotransferase (ALT) levels in patients with ACR and in patients without ACR were 198 ± 27 and 153 ± 34 U/L, respectively. Among the 7 proteins for which ELISA assays were available, C4 and C1q were both independent predictors of ACR. C4 had the greatest predictivity for differentiating patients with or without ACR. A C4 level ≤ 0.31 g/L had a sensitivity of 97%, a specificity of 62%, a positive predictive value of 74%, and a negative predictive value of 94%. A C4 level ≤ 0.31 g/L and an ALT level ≥ 70 IU/mL together had a sensitivity of 96%, a specificity of 81%, a positive predictive value of 86%, and a negative predictive value of 94%. In summary, in this exploratory analysis, serum C4 and ALT levels were highly predictive of ACR in liver transplant recipients. Confirmation in a prospective, larger, and diverse population is needed.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21618694      PMCID: PMC3293624          DOI: 10.1002/lt.22266

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  68 in total

1.  Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time?

Authors:  Paul J Thuluvath; Karen L Krok
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

Review 2.  Chemistry and biology of the immunophilins and their immunosuppressive ligands.

Authors:  S L Schreiber
Journal:  Science       Date:  1991-01-18       Impact factor: 47.728

3.  Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging.

Authors:  M van Lohuizen; S Verbeek; B Scheijen; E Wientjens; H van der Gulden; A Berns
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

4.  Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver.

Authors:  B Maharaj; R J Maharaj; W P Leary; R M Cooppan; A D Naran; D Pirie; D J Pudifin
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

5.  Myeloid-associated differentiation antigens on stem cells and their progeny identified by monoclonal antibodies.

Authors:  R G Andrews; B Torok-Storb; I D Bernstein
Journal:  Blood       Date:  1983-07       Impact factor: 22.113

6.  Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies.

Authors:  Ashok Jain; Charlotte Ryan; Ravi Mohanka; Mark Orloff; Peter Abt; Joan Romano; Leah Bryan; Pam Batzold; Parvez Mantry; Adel Bozorgzadeh
Journal:  Clin Transplant       Date:  2006 Sep-Oct       Impact factor: 2.863

7.  C4d: a marker for hepatic transplant rejection.

Authors:  R Lorho; B Turlin; N Aqodad; N Triki; A S de Lajarte-Thirouard; C Camus; M Lakehal; P Compagnon; E Dupont-Bierre; B Meunier; K Boudjema; M Messner
Journal:  Transplant Proc       Date:  2006-09       Impact factor: 1.066

8.  Isobaric tags for relative and absolute quantitation (iTRAQ) reproducibility: Implication of multiple injections.

Authors:  Poh Kuan Chong; Chee Sian Gan; Trong Khoa Pham; Phillip C Wright
Journal:  J Proteome Res       Date:  2006-05       Impact factor: 4.466

9.  Morphologic and cytochemical characterization of adult lymphoid leukemias which express myeloid antigen.

Authors:  F R Davey; R Mick; D A Nelson; J MacCallum; R E Sobol; I Royston; J Cuttner; R R Ellison; C D Bloomfield
Journal:  Leukemia       Date:  1988-07       Impact factor: 11.528

10.  A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells.

Authors:  J D Griffin; D Linch; K Sabbath; P Larcom; S F Schlossman
Journal:  Leuk Res       Date:  1984       Impact factor: 3.156

View more
  9 in total

1.  New Approaches to the Diagnosis of Rejection and Prediction of Tolerance in Liver Transplantation.

Authors:  Timucin Taner; Julia Bruner; Juliet Emamaullee; Eliano Bonaccorsi-Riani; Ali Zarrinpar
Journal:  Transplantation       Date:  2022-05-16       Impact factor: 5.385

2.  Proteoforms in Peripheral Blood Mononuclear Cells as Novel Rejection Biomarkers in Liver Transplant Recipients.

Authors:  T K Toby; M Abecassis; K Kim; P M Thomas; R T Fellers; R D LeDuc; N L Kelleher; J Demetris; J Levitsky
Journal:  Am J Transplant       Date:  2017-06-27       Impact factor: 8.086

3.  Identification of Novel and Noninvasive Biomarkers of Acute Cellular Rejection After Liver Transplantation by Protein Microarray.

Authors:  Keita Okubo; Hiroshi Wada; Atsushi Tanaka; Hidetoshi Eguchi; Masahide Hamaguchi; Akira Tomokuni; Yoshito Tomimaru; Tadafumi Asaoka; Naoki Hama; Koichi Kawamoto; Shogo Kobayashi; Shigeru Marubashi; Hiroaki Nagano; Noriko Sakaguchi; Hiroyoshi Nishikawa; Yuichiro Doki; Masaki Mori; Shimon Sakaguchi
Journal:  Transplant Direct       Date:  2016-11-18

4.  Discovery and validation of a novel blood-based molecular biomarker of rejection following liver transplantation.

Authors:  Josh Levitsky; Sumeet K Asrani; Thomas Schiano; Adyr Moss; Kenneth Chavin; Charles Miller; Kexin Guo; Lihui Zhao; Manoj Kandpal; Nancy Bridges; Merideth Brown; Brian Armstrong; Sunil Kurian; Anthony J Demetris; Michael Abecassis
Journal:  Am J Transplant       Date:  2020-05-25       Impact factor: 8.086

5.  Diagnostic Biomarkers to Diagnose Acute Allograft Rejection After Liver Transplantation: Systematic Review and Meta-Analysis of Diagnostic Accuracy Studies.

Authors:  Felix Krenzien; Eriselda Keshi; Katrin Splith; Silvan Griesel; Kaan Kamali; Igor M Sauer; Linda Feldbrügge; Johann Pratschke; Annekatrin Leder; Moritz Schmelzle
Journal:  Front Immunol       Date:  2019-04-11       Impact factor: 7.561

6.  Identification of HO-1 as a novel biomarker for graft acute cellular rejection and prognosis prediction after liver transplantation.

Authors:  Junjun Jia; Yu Nie; Lei Geng; Jianhui Li; Jimin Liu; Yifan Peng; Junjie Huang; Haiyang Xie; Lin Zhou; Shu-Sen Zheng
Journal:  Ann Transl Med       Date:  2020-03

7.  Oxidative stress and apoptosis in a pig model of brain death (BD) and living donation (LD).

Authors:  Philipp Stiegler; Michael Sereinigg; Andreas Puntschart; Andrea Bradatsch; Thomas Seifert-Held; Iris Wiederstein-Grasser; Bettina Leber; Elke Stadelmeyer; Nadia Dandachi; Siglinde Zelzer; Florian Iberer; Vanessa Stadlbauer
Journal:  J Transl Med       Date:  2013-10-02       Impact factor: 5.531

8.  Serum proteomic predicts effectiveness and reveals potential biomarkers for complications in liver transplant patients.

Authors:  Wenjing Wang; Bo Wang; Chang Liu; Jing Yan; Xiaofan Xiong; Xiaofei Wang; Juan Yang; Bo Guo; Chen Huang
Journal:  Aging (Albany NY)       Date:  2020-06-12       Impact factor: 5.682

9.  Prediction of Liver Transplant Rejection With a Biologically Relevant Gene Expression Signature.

Authors:  Josh Levitsky; Manoj Kandpal; Kexin Guo; Lihui Zhao; Sunil Kurian; Thomas Whisenant; Michael Abecassis
Journal:  Transplantation       Date:  2021-07-22       Impact factor: 5.385

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.